| - Industry | - Sector | Mr. Inas Said Ph.D. CEO | CNSX Exchange | - ISIN |
| Israel Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Rise Nano Optics Ltd. is a pioneering health technology company based in Vancouver, British Columbia, dedicated to advancing vision care through innovative nanotechnology lens solutions. The company specializes in the selective filtering of high-energy visible light wavelengths, employing its patented SPECTRAGUARD™ technology. This cutting-edge approach integrates nanomaterial innovation, comprehensive ophthalmic research, and scalable optical engineering to enhance visual comfort while protecting eye health.
Each lens is designed to block 100% of harmful ultraviolet light and up to 90% of intense visible light wavelengths between 400-600 nm, including the known harmful blue light. Notably, these lenses help maintain natural visual clarity and color perception, thereby reducing vision stress, particularly for patients suffering from diabetes-related eye conditions such as cataracts and retinopathy. The company's FDA Class I exempt medical device classification allows for safe use in various clinical applications. In addition to its focus on patient care, Rise Nano Optics also aims to make a significant impact on the broader consumer eyewear market, offering solutions that provide comprehensive light protection while ensuring vision remains unoverly darkened.
These advanced lenses utilize proprietary nanotechnology to effectively block 100% of ultraviolet light and up to 90% of intense light within the 400-600 nm wavelength range. Designed for both clinical and everyday use, these lenses help minimize harmful light exposure while preserving natural visual clarity.
Targeted towards eye health professionals, Rise Nano Optics offers clinical solutions specifically for patients with diabetic eye conditions. These lenses help to alleviate vision stress from intense sunlight, improving overall comfort and quality of life for individuals suffering from ailments such as cataracts and retinopathy.
In addition to its clinical applications, the company provides consumer eyewear options designed for everyday use. These products ensure users benefit from enhanced light protection without sacrificing visual clarity, catering to consumers who are increasingly concerned about eye health in the presence of harmful blue light exposure.
Rise Nano Optics is committed to ongoing research and development to continuously improve its technology and product offerings. By investing in innovation, the company aims to stay at the forefront of advancements in nanotechnology and optics, ultimately enhancing its product efficacy and consumer benefits.